TAK-259 is an orally active and selective alpha1D adrenoceptor (alpha1D-AR) antagonist with a Ki value of 1.1 nM. TAK-259 inhibits excessive contraction of bladder smooth muscle and prolongs voiding intervals. TAK-259 is promising for research of urinary system diseases[1][2].
Molecular Weight:
374.24
CAS Number:
[1192348-73-4]
Formula:
C14H13Cl2N3O3S
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted